Overcoming research challenges in resource-limited settings: perspectives from Thailand.
Chewapreecha C. and Chewprecha T., (2025), Nat Rev Microbiol, 23, 141 - 142
Genetic diversity, determinants, and dissemination of Burkholderia pseudomallei lineages implicated in melioidosis in Northeast Thailand.
Seng R. et al, (2024), Nat Commun, 15
Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study.
Pakdeerat S. et al, (2024), Lancet Microbe, 5, e379 - e389
Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021.
Tantirat P. et al, (2024), Emerg Infect Dis, 30, 791 - 794
Integrating Genomic Data with the Development of CRISPR-Based Point-of-Care-Testing for Bacterial Infections.
Wanitchanon T. et al, (2024), Curr Clin Microbiol Rep, 11, 241 - 258
BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection
Angchagun K. et al, (2023), Wellcome Open Research, 8, 347 - 347
BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection.
Angchagun K. et al, (2023), Wellcome Open Res, 8
Phenotypic and genetic alterations of Burkholderia pseudomallei in patients during relapse and persistent infections.
Seng R. et al, (2023), Front Microbiol, 14
A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance.
Patchsung M. et al, (2022), CRISPR J
Pneumococcal within-host diversity during colonization, transmission and treatment.
Tonkin-Hill G. et al, (2022), Nat Microbiol, 7, 1791 - 1804
Highly specific and sensitive detection of Burkholderia pseudomallei genomic DNA by CRISPR-Cas12a.
Wongpalee SP. et al, (2022), PLoS Negl Trop Dis, 16